EASL Clinical Practice Guidelines

References

[1]Scheinberg IH, Sternlieb I. Wilsons disease. In: Smith Jr LH, editor. Major problems in internal medicine, vol. 23. Philadelphia, PA: WB Saunders; 1984. p. 2535.

[2]Gitlin, J.D. Wilson disease. Gastroenterology. 2003; 125: 18681877
PubMed | Scopus (156)

[3]Tao, T.Y. and Gitlin, J.D. Hepatic copper metabolism: insights from genetic disease. Hepatology. 2003; 37: 12411247
CrossRef | PubMed | Scopus (58)

[4]Lutsenko, S. and Petris, M.J. Function and regulation of the mammalian copper-transporting ATPases: insights from biochemical and cell biological approaches. J Membr Biol. 2003; 191: 112
CrossRef | PubMed | Scopus (108)

[5]Ferenci, P., Czlonkowska, A., Merle, U., Szalay, F., Gromadzka, G., Yurdaydin, C. et al. Late onset Wilson disease. Gastroenterology. 2007; 132: 12941298
PubMed | Scopus (51)

[6]Bachmann H, Lssner J, Khn HJ, Siegemund R. Occurrence, genetics and epidemiology of Wilsons disease in East Germany. In: Czlonkowska A, van der Hamer CJA, editors. Proc. 5th. Intern. Symposium on Wilsons disease. Technical Univ. Delft 1991. p. 121128.

[7]Reilly, M., Daly, L., and Hutchinson, M. An epidemiological study of Wilsons disease in the Republic of Ireland. J Neurol Neurosurg Psychiatry. 1993; 56: 298300
CrossRef | PubMed

[8]Wilson disease mutation database. Available from: http://www.wilsondisease.med.ualberta.ca/database.asp.
http://www.wilsondisease.med.ualberta.ca/database.asp

[9]Wilson, D.C., Phillips, M.J., Cox, D.W., and Roberts, E.A. Severe hepatic Wilsons disease in preschool-aged children. J Pediatr. 2000; 137: 719722
PubMed | Scopus (34)

[10]Ala, A., Borjigin, J., Rochwarger, A., and Schilsky, M. Wilson disease in septuagenarian siblings: raising the bar for diagnosis. Hepatology. 2005; 41: 668670
CrossRef | PubMed | Scopus (65)

[11]Czlonkowska, A., Rodo, M., and Gromadzka, G. Late onset Wilsons disease: therapeutic implications. Mov Disord. 2008; 23: 897899
CrossRef | Scopus (10)

[12]Steindl, P., Ferenci, P., Dienes, H.P., Grimm, G., Pabinger, I., Madl, C.H. et al. Wilsons disease in patients presenting with liver disease: a diagnostic challenge. Gastroenterology. 1997; 113: 212218
PubMed | Scopus (198)

[13]Gow, P.J., Smallwood, R.A., Angus, P.W., Smith, A.L., Wall, A.J., and Sewell, R.B. Diagnosis of Wilsons disease: an experience over three decades. Gut. 2000; 46: 415419
CrossRef | PubMed | Scopus (107)

[14]Sanchez-Albisua I, Garde T, Hierro L, Camarena C, Frauca E, de la Vega A, et al. A high index of suspicion: the key to an early diagnosis of Wilsons disease in childhood. J Pediatr Gastroenterol Nutr 1999;28:186190.

[15]Cairns, J.E., Williams, H.P., and Walshe, J.M. Sunflower cataract in Wilsons disease. Br Med J. 1969; 3: 9596
CrossRef | PubMed

[16]Walshe, J.M. and Dixon, A.K. Dangers of non-compliance in Wilsons disease. Lancet. 1986; 12: 845847
Abstract

[17]Eisenbach, C., Sieg, O., Stremmel, W., Encke, J., and Merle, U. Diagnostic criteria for acute liver failure due to Wilson disease. World J Gastroenterol. 2007; 13: 17111714
PubMed

[18]Walshe, J.M. The liver in Wilsons disease. in: L. Schiff, E.R. Schiff (Eds.) Diseases of the Liver. 6th ed. Lippincott, Philadelphia; 1987: 10371050

[19]Saito, T. Presenting symptoms and natural history of Wilson disease. Eur J Pediatr. 1987; 146: 261265
CrossRef | PubMed

[20]Czlonkowska, A., Gromadzka, G., Buttner, J., and Chabik, G. Clinical features of hemolysis, elevated liver enzymes and low platelet count syndrome in undiagnosed Wilson disease: report of two cases. Arch Gynecol Obstet. 2009; 281: 129134
CrossRef | PubMed | Scopus (1)

[21]Czlonkowska, A. A study of haemolysis in Wilsons disease. J Neurol Sci. 1972; 16: 303314
PubMed

[22]Brewer GJ. Neurologically presenting Wilsons Disease. CNS Drugs 2005;19:185192.

[23]LeWitt, P.A. and Czlonkowska, A. Wilsons disease. in: R.P. Lisak, D.D. Truong, W.M. Carroll, R. Bhidayasiri (Eds.) International neurology, a clinical approach. Wiley-Blackwell, Oxford UK; 2009: 644647

[24]Svetel, M., Potrebic, A., Pekmezovic, T., Tomic, A., Kresojevic, N., Jesic, R. et al. Neuropsychiatric aspects of treated Wilsons disease. Parkinsonism Relat Disord. 2009; 15: 772775
PubMed | Scopus (5)

[25]Seniw, J., Mroziak, B., Czlonkowska, A., and Jędryka-Goral, A. Self-rated emotional functioning of patients with neurological or asymptomatic form of Wilsons disease. Clin Neuropsychol. 2004; 17: 367373

[26]Seniw, J., Bąk, T., Gajda, J., Poniatowska, R., and Czlonkowska, A. Cognitive functioning in neurologically symptomatic and asymptomatic forms of Wilsons disease. Mov Disord. 2002; 17: 10771108
CrossRef | PubMed | Scopus (22)

[27]Merle, U., Schaefer, M., Ferenci, P., and Stremmel, W. Clinical Presentation, diagnosis and long-term outcome of Wilson disease a cohort study. Gut. 2007; 56: 115120
CrossRef | PubMed | Scopus (139)

[28]Ferenci, P., Steindl-Munda, P., Vogel, W., Jessner, W., Gschwantler, M., Stauber, R. et al. Diagnostic value of quantitative hepatic copper determination in patients with Wilson disease. Clin Gastroenterol Hepatol. 2005; 3: 811818
PubMed | Scopus (62)

[29]Azizi, E., Eshel, G., and Aladjem, M. Hypercalciuria and nephrolithiasis as a presenting sign in Wilson disease. Eur J Pediatr. 1989; 148: 548549
CrossRef | PubMed

[30]Nakada, S.Y., Brown, M.R., and Rabinowitz, R. Wilsons disease presenting as symptomatic urolithiasis: a case report and review of the literature. J Urol. 1994; 152: 978979
PubMed

[31]Factor SM, Cho S, Sternlieb I, Scheinberg IH, Goldfischer S. The cardiomyopathy of Wilsons disease. Myocardial alterations in nine cases. Virchows Arch [Pathol Anat] 1982;397:301311.

[32]Chu, C.C., Huang, C.C., and Chu, N.S. Recurrent hypokalemic muscle weakness as an initial manifestation of Wilsons disease. Nephron. 1996; 73: 477479
CrossRef | PubMed

[33]Golding, D.N. and Walshe, J.M. Arthropathy of Wilsons disease. Study of clinical and radiological features in 32 patients. Ann Rheum Dis. 1977; 36: 99111
CrossRef | PubMed

[34]Carpenter, T.O., Carnes, D.L. Jr, and Anast, C.S. Hypoparathyroidism in Wilsons disease. N Engl J Med. 1983; 309: 873877
CrossRef | PubMed

[35]Weizman, Z., Picard, E., Barki, Y., and Moses, S. Wilsons disease associated with pancreatitis. J Pediatr Gastroenterol Nutr. 1988; 7: 931933
CrossRef | PubMed

[36]Klee, J.G. Undiagnosed Wilsons disease as cause of unexplained miscarriage. Lancet. 1979; 2: 423
Abstract | PubMed

[37]Tarnacka, B., Rodo, M., Cichy, S., and Czlonkowska, A. Procreation ability in Wilsons disease. Acta Neurol Scand. 2000; 101: 395398
CrossRef | PubMed | Scopus (15)

[38]Czlonkowska, A., Tarnacka, B., Litwin, T., Gajda, J., and Rodo, M. Wilsons disease cause of mortality in 164 patients during 19922003 observation period. J Neurol. 2005; 252: 698703
CrossRef | PubMed | Scopus (16)

[39]Stremmel, W., Meyerrose, K.W., Niederau, C., Hefter, H., Kreuzpaintner, G., and Strohmeyer, G. Wilsons disease: clinical presentation, treatment, and survival. Ann Intern Med. 1991; 115: 720726
CrossRef | PubMed

[40]Nazer, H., Ede, R.J., Mowat, A.P., and Williams, R. Wilsons disease: clinical presentation and use of prognostic index. Gut. 1986; 27: 13771381
CrossRef | PubMed

[41]Dhawan, A., Taylor, R.M., Cheeseman, P., De Silva, P., Katsiyiannakis, L., and Mieli-Vergani, G. Wilsons disease in children: 37-year experience and revised Kings score for liver transplantation. Liver Transplant. 2005; 11: 441448
CrossRef | PubMed | Scopus (82)

[42]Arnon, R., Annunziato, R., Schilsky, M., Miloh, T., Willis, Sturdevant, M. et al. Liver transplantation for children with Wilson disease: comparison of outcomes between children and adults. Clin Transplant. 2011; 25: E52E60
CrossRef | PubMed | Scopus (11)

[43]Cauza, E., Maier-Dobersberger, T., and Ferenci, P. Plasma ceruloplasmin as screening test for Wilsons disease. J Hepatol. 1997; 27: 358362
PubMed | Scopus (61)

[44]Ferenci, P., Caca, K., Loudianos, G., Mieli-Vergani, G., Tanner, S., Sternlieb, I. et al. Diagnosis and phenotypic classification of Wilson disease. Liver Int. 2003; 23: 139142
CrossRef | PubMed

[45]Nicastro, E., Ranucci, G., Vajro, P., Vegnente, A., and Iorio, R. Re-evaluation of the diagnostic criteria for Wilson disease in children with mild liver disease. Hepatology. 2010; 52: 19481956
CrossRef | PubMed | Scopus (22)

[46]Frieden, E. and Hsieh, H.S. Ceruloplasmin: the copper transport protein with essential oxidase activity. Adv Enzymol. 1976; 44: 187236
PubMed

[47]Gromadzka, G., Chabik, G., Mendel, T., Wierzchowska, A., Rudnicka, M., and Czlonkowska, A. Middle-aged heterozygous carriers of Wilsons disease do not present with significant phenotypic deviations related to copper metabolism. J Genet. 2010; 89: 463467
CrossRef | PubMed | Scopus (1)

[48]Harris, Z.L., Klomp, L.W., and Gitlin, J.D. Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis. Am J Clin Nutr. 1998; 67: S972S977
PubMed

[49]Perman, J.A., Werlin, S.L., Grand, R.J., and Watkins, J.B. Laboratory measures of copper metabolism in the differentiation of chronic active hepatitis and Wilson disease in children. J Pediatr. 1979; 94: 564568
PubMed

[50]Korman, J.D., Volenberg, I., Balko, J., Webster, J., Schiodt, F.V., Squires, R.H. Jr. et al. Screening for Wilson disease in acute liver failure: a comparison of currently available diagnostic tests. Hepatology. 2008; 48: 11671174
CrossRef | PubMed | Scopus (39)

[51]Merle, U., Eisenbach, C., Weiss, K.H., Tuma, S., and Stremmel, W. Serum ceruloplasmin oxidase activity is a sensitive and highly specific diagnostic marker for Wilsons disease. J Hepatol. 2009; 51: 925930
PubMed | Scopus (10)

[52]Danks DM. Disorders of copper transport. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic basis of inherited disease. New York: McGraw-Hill; 1995. p. 41254158.

[53]Roberts, E.A. and Cox, D.W. Wilson disease. Baillieres Clin Gastroenterol. 1998; 12: 237256
PubMed | Scopus (51)

[54]Gross, J.B. Jr., Ludwig, J., Wiesner, R.H., McCall, J.T., and LaRusso, N.F. Abnormalities in tests of copper metabolism in primary sclerosing cholangitis. Gastroenterology. 1985; 89: 272278
PubMed

[55]Giacchino, R., Marazzi, M.G., Barabino, A., Fasce, L., Ciravegna, B., Famularo, L. et al. Syndromic variability of Wilsons disease in children. Clinical study of 44 cases. Ital J Gastroenterol Hepatol. 1997; 29: 155161
PubMed

[56]Tu, J.B. and Blackwell, R.Q. Studies on levels of penicillamine-induced cupriuresis in heterozygotes of Wilsons disease. Metabolism. 1967; 16: 507513
PubMed

[57]Frommer, D.J. Urinary copper excretion and hepatic copper concentrations in liver disease. Digestion. 1981; 21: 169178
CrossRef | PubMed

[58]Martins da Costa C, Baldwin D, Portmann B, Lolin Y, Mowat AP, Mieli-Vergani G. Value of urinary copper excretion after penicillamine challenge in the diagnosis of Wilsons disease. Hepatology 1992;15:609615.

[59]Muller, T., Koppikar, S., Taylor, R.M., Carragher, F., Schlenck, B., Heinz-Erian, P. et al. Re-evaluation of the penicillamine challenge test in the diagnosis of Wilsons disease in children. J Hepatol. 2007; 47: 270276
PubMed | Scopus (26)

[60]Song, Y.M. and Chen, M.D. A single determination of liver copper concentration may misdiagnose Wilsons disease. Clin Biochem. 2000; 33: 589590
CrossRef | PubMed | Scopus (15)

[61]Tanner, M.S. Indian childhood cirrhosis and Tyrolean childhood cirrhosis. Disorders of a copper transport gene?. Adv Exp Med Biol. 1999; 448: 127137
CrossRef | PubMed

[62]Ludwig, J., Moyer, T.P., and Rakela, J. The liver biopsy diagnosis of Wilsons disease. Methods in pathology. Am J Clin Pathol. 1994; 102: 443446
PubMed

[63]Strohmeyer, F.W. and Ishak, K.G. Histology of the liver in Wilsons disease: a study of 34 cases. Am J Clin Pathol. 1980; 73: 1224
PubMed

[64]Strand, S., Hofmann, W.J., Grambihler, A., Hug, H., Volkmann, M., Otto, G. et al. Hepatic failure and liver cell damage in acute Wilsons disease involve CD95 (APO-1/Fas) mediated apoptosis. Nat Med. 1998; 4: 588593
CrossRef | PubMed | Scopus (159)

[65]Goldfischer, S. and Sternlieb, I. Changes in the distribution of hepatic copper in relation to the progression of Wilsons disease (hepatolenticular degeneration). Am J Pathol. 1968; 53: 883901
PubMed

[66]Sternlieb, I. Mitochondrial and fatty changes in hepatocytes of patients with Wilsons disease. Gastroenterology. 1968; 55: 354367
PubMed

[67]Leinweber, B., Moller, J.C., Scherag, A., Reuner, U., Gunther, P., Lang, C.J.G. et al. Evaluation of the Unified Wilsons Disease Rating Scale (UWDRS) in German patients with treated Wilsons disease. Mov Disord. 2008; 23: 5462
CrossRef | PubMed | Scopus (11)

[68]Czlonkowska, A., Tarnacka, B., Moller, J.C., Leinweber, B., Bandmann, O., Woimant, F. et al. Unified Wilsons Disease Rating Scale a proposal for the neurological scoring of Wilsons disease patients. Neurol Neurochir Pol. 2007; 41: 112
PubMed

[69]van Wassenaer-van Hall HN, van den Heuvel AG, Algra A, Hoogenraad TU, Mali WP. Wilson disease: findings at MR imaging and CT of the brain with clinical correlation. Radiology 1996;198:531536.

[70]Tarnacka, B., Szeszkowski, W., Gołębiowski, M., and Czlonkowska, A. MR Spectroscopy in monitoring the treatment of Wilsons disease patients. Mov Disord. 2008; 23: 15601566
CrossRef | PubMed | Scopus (7)

[71]Jacobs, D.A., Markowitz, C.E., Liebeskind, D.S., and Galetta, S.L. The double panda sign in Wilsons disease. Neurology. 2003; 61: 969
CrossRef | PubMed

[72]Prashanth, L.K., Sinha, S., Taly, A.B., and Vasudev, M.K. Do MRI features distinguish Wilsons disease from other early onset extrapyramidal disorders? An analysis of 100 cases. Mov Disord. 2010; 25: 672678
CrossRef | PubMed | Scopus (13)

[73]Piga, M., Murru, A., Satta, L., Serra, A., Sias, A., Loi, G. et al. SPECT in the diagnosis of early neurological involvement in Wilsons disease. Eur J Nucl Med Mol Imaging. 2008; 35: 716724
CrossRef | PubMed | Scopus (7)

[74]Walter, U., Krlikowski, K., Tarnacka, B., Benecke, R., Czlonkowska, A., and Dressler, D. Sonographic detection of basal ganglia lesions in asymptomatic and symptomatic Wilson disease. Neurology. 2005; 64: 17261732
CrossRef | PubMed | Scopus (58)

[75]Walter, U. Transcranial sonography in brain disorders with trace metal accumulation. Int Rev Neurobiol. 2010; 90: 166178
CrossRef | PubMed | Scopus (7)

[76]Grimm, G., Oder, W., Prayer, L., Ferenci, P., and Madl, C.H. Prospective follow-up study in Wilsons disease. Lancet. 1990; 336: 963964
Abstract | PubMed | Scopus (28)

[77]Grimm, G., Madl, C.H., Katzenschlager, R., Oder, W., Ferenci, P., and Gangl, A. Detailed evaluation of brain dysfunction in patients with Wilsons disease. EEG Clin Neurophysiol. 1992; 82: 119124
PubMed

[78]Ferenci, P. Wilsons disease. Clin Gastroenterol Hepatol. 2005; 3: 726733
PubMed | Scopus (42)

[79]Ferenci, P. Regional distribution of mutations of the ATP7B gene in patients with Wilson disease impact on genetic testing. Hum Genet. 2006; 120: 151159
CrossRef | PubMed | Scopus (72)

[80]Loudianos, G., Dessi, V., Lovicu, M., Angius, A., Figus, A.L., Lilliu, F. et al. Molecular characterization of Wilson disease in the Sardinian population evidence of a founder effect. Hum Mutat. 1999; 14: 294303
CrossRef | PubMed | Scopus (74)

[81]Loudianos, G., Dessi, V., Lovicu, M., Angius, A., Altuntas, B., Giacchino, R. et al. Mutation analysis in patients of Mediterranean descent with Wilson disease: identification of 19 novel mutations. J Med Genet. 1999; 36: 833836
PubMed

[82]Kim, E.K., Yoo, O.J., Song, K.Y., Yoo, H.W., Choi, S.Y., Cho, S.W. et al. Identification of three novel mutations and a high frequency of the Arg778Leu mutation in Korean patients with Wilson disease. Hum Mutat. 1998; 11: 275278
CrossRef | PubMed | Scopus (74)

[83]Nanji, M.S., Nguyen, V.T., Kawasoe, J.H., Inui, K., Endo, F., Nakajima, T. et al. Haplotype and mutation analysis in Japanese patients with Wilson disease. Am J Hum Genet. 1997; 60: 14231429
Abstract | Full Text PDF | PubMed

[84]Shimizu, N., Nakazono, H., Takeshita, Y., Ikeda, C., Fujii, H., Watanabe, A. et al. Molecular analysis and diagnosis in Japanese patients with Wilsons disease. Pediatr Int. 1999; 41: 409413
CrossRef | PubMed | Scopus (32)

[85]Berman, D.H., Leventhal, R.I., Gavaler, J.S., Cadoff, E.M., and Van Thiel, D.H. Clinical differentiation of acute Wilsonian hepatitis from other causes of hepatic failure. Gastroenterology. 1991; 100: 11291134
PubMed

[86]Ferenci, P. Diagnosis and current therapy of Wilsons disease. Aliment Pharmacol Ther. 2004; 19: 157165
CrossRef | PubMed | Scopus (66)

[87]Wiggelinkhuizen, M., Tilanus, M.E., Bollen, C.W., and Houwen, R.H. Systematic review: clinical efficacy of chelator agents and zinc in the initial treatment of Wilson disease. Aliment Pharmacol Ther. 2009; 29: 947958
CrossRef | PubMed | Scopus (32)

[88]Scheinberg, I.H., Sternlieb, I., Schilsky, M., and Stockert, R.J. Penicillamine may detoxify copper in Wilsons disease. Lancet. 1987; 2: 95
Abstract | PubMed

[89]Siegel, R.C. Collagen cross-linking effect of D-penicillamine on crosslinking in vitro. J Biol Chem. 1977; 252: 254259
PubMed

[90]Lipsky, P.E. and Ziff, M. The effect of D-penicillamine on mitogen-induced human lymphocyte proliferation: synergistic inhibition by D-penicillamine and copper salts. J Immunol. 1978; 120: 10061013
PubMed

[91]Czlonkowska, A. The influence of prolonged treatment with D-penicillamine on the immune response in Wilsons disease. Eur J Clin Pharmacol. 1977; 12: 265271
CrossRef | PubMed

[92]Brewer, G.J., Yuzbasiyan-Gurkan, V., Lee, D.Y., and Appelman, H. Treatment of Wilsons disease with zinc. VI: initial treatment studies. J Lab Clin Med. 1989; 114: 633638
PubMed

[93]Perrett, D. The metabolism and pharmacology of D-penicillamine in man. J Rheumatol Suppl. 1981; 7: 4150
PubMed

[94]Kukovetz, W.R., Beubler, E., Kreuzig, F., Moritz, A.J., Nimberger, G., and Werner-Breitnecker, L. Bioavailability and pharmacokinetics of D-penicillamine. J Rheumatol. 1983; 10: 9094
PubMed

[95]Walshe, J.M. Copper chelation in patients with Wilsons disease. A comparison of penicillamine and triethylene tetramine dihydrochloride. Q J Med. 1973; 42: 441452
PubMed

[96]Czlonkowska, A., Gajda, J., and Rodo, M. Effects of long-term treatment in Wilsons disease with D-penicillamine and zinc sulphate. J Neurol. 1996; 243: 269273
CrossRef | PubMed | Scopus (53)

[97]Brewer, G.J., Terry, C.A., Aisen, A.M., and Hill, G.M. Worsening of neurologic syndrome in patients with Wilsons disease with initial penicillamine therapy. Arch Neurol. 1987; 44: 490493
CrossRef | PubMed

[98]Medici, V., Trevisan, C.P., DInca, R., Barollo, M., Zancan, L., Fagiuoli, S. et al. Diagnosis and management of Wilsons disease: results of a single center experience. J Clin Gastroenterol. 2006; 40: 936941
CrossRef | PubMed | Scopus (37)

[99]Becuwe, C., Dalle, S., Ronger-Savle, S., Skowron, F., Balme, B., Kanitakis, J. et al. Elastosis perforans serpiginosa associated with pseudo-pseudoxanthoma elasticum during treatment of Wilsons disease with penicillamine. Dermatology. 2005; 210: 6063
CrossRef | PubMed | Scopus (22)

[100]Czlonkowska, A. Myasthenia syndrome during penicillamine treatment. Brit Med J. 1975; 2: 726727
CrossRef | PubMed

[101]Shiono, Y., Wakusawa, S., Hayashi, H., Takikawa, T., Yano, M., Okada, T. et al. Iron accumulation in the liver of male patients with Wilson disease. Am J Gastroenterol. 2001; 96: 31473151
CrossRef | PubMed

[102]Walshe, J.M. Treatment of Wilsons disease with trientine (triethylene tetramine) dihydrochloride. Lancet. 1982; 1: 643647
Abstract | PubMed

[103]Kodama, H., Murata, Y., Iitsuka, T., and Abe, T. Metabolism of administered triethylene tetramine dihydrochloride in humans. Life Sci. 1997; 61: 899907
CrossRef | PubMed | Scopus (34)

[104]Borthwick, T.R., Benson, G.D., and Schugar, H.J. Copper chelating agents. A comparison of cupruretic responses to various tetramines and D-penicillamine. J Lab Clin Med. 1980; 95: 575580
PubMed

[105]Sarkar, B., Sass-Kortsak, A., Clarke, R., Laurie, S.H., and Wei, P. A comparative study of in vitro and in vivo interaction of D-penicillamine and triethylene-tetramine with copper. Proc R Soc Med. 1977; 70: 1318
PubMed

[106]Walshe, J.M. The management of Wilsons disease with trienthylene tetramine 2HC1 (Trien 2HC1). Prog Clin Biol Res. 1979; 34: 271280
PubMed

[107]Scheinberg, I.H., Jaffe, M.E., and Sternlieb, I. The use of trientine in preventing the effects of interrupting penicillamine therapy in Wilsons disease. N Engl J Med. 1987; 317: 209213
CrossRef | PubMed

[108]Saito, H., Watanabe, K., Sahara, M., Mochizuki, R., Edo, K., and Ohyama, Y. Triethylene-tetramine (trien) therapy for Wilsons disease. Tohoku J Exp Med. 1991; 164: 2935
CrossRef | PubMed

[109]Santos Silva, E.E., Sarles, J., Buts, J.P., and Sokal, E.M. Successful medical treatment of severely decompensated Wilson disease. J Pediatr. 1996; 128: 285287
PubMed | Scopus (24)

[110]Brewer, G.J., Dick, R.D., Johnson, V., Wang, Y., Yuzbasiyan-Gurkan, V., Kluin, K. et al. Treatment of Wilsons disease with ammonium tetrathiomolybdate: I. Initial therapy in 17 neurologically affected patients. Arch Neurol. 1994; 51: 545554
CrossRef | PubMed

[111]Alvarez, H.M., Xue, Y., Robinson, C.D., Canalizo-Hernndez, M.A., Marvin, R.G., Kelly, R.A. et al. Tetrathiomolybdate inhibits copper trafficking proteins through metal cluster formation. Science. 2010; 327: 331334
CrossRef | PubMed | Scopus (34)

[112]Ogra, Y. and Suzuki, K.T. Targeting of tetrathiomolybdate on the copper accumulating in the liver of LEC rats. J Inorg Biochem. 1998; 70: 4955
CrossRef | PubMed | Scopus (16)

[113]Brewer, G.J., Askari, F., Dick, R.B., Sitterly, J., Fink, J.K., Carlson, M. et al. Treatment of Wilsons disease with tetrathiomolybdate: V. Control of free copper by tetrathiomolybdate and a comparison with trientine. Transl Res. 2009; 154: 7077
PubMed | Scopus (24)

[114]Brewer, G.J., Hedera, P., Kluin, K.J., Carlson, M., Askari, F., Dick, R.B. et al. Treatment of Wilson disease with ammonium tetrathiomolybdate. III: initial therapy in a total of 55 neurologically affected patients and follow-up with zinc therapy. Arch Neurol. 2003; 60: 379385
CrossRef | PubMed | Scopus (86)

[115]Brewer, G.J., Askari, F., Lorincz, M.T., Carlson, M., Schilsky, M., Kluin, K.J. et al. Treatment of Wilson disease with ammonium tetrathiomolybdate. IV: comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease. Arch Neurol. 2006; 63: 521527
CrossRef | PubMed | Scopus (91)

[116]Karunajeewa, H., Wall, A., Metz, J., and Grigg, A. Cytopenias secondary to copper depletion complicating ammonium tetrathiomolybdate therapy for Wilsons disease. Aust NZ J Med. 1998; 28: 215216
CrossRef | PubMed

[117]Medici, V., Trevisan, C.P., Bigotto, M.A., DInca, R., Martines, D., Dal Pont, E. et al. Adverse reaction after tetrathiomolybdate treatment for Wilsons disease: a case report. Mov Disord. 2006; 21: 20302032
CrossRef | PubMed | Scopus (6)

[118]Pan, Q., Kleer, C.G., van Golen, K.L., Irani, J., Bottema, K.M., Bias, C. et al. Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis. Cancer Res. 2002; 62: 48544859
PubMed

[119]Hoogenraad, T.U., Koevoet, R., and de Ruyter Korver, E.G. Oral zinc sulphate as long-term treatment in Wilsons disease (hepatolenticular degeneration). Eur Neurol. 1979; 18: 205211
CrossRef | PubMed

[120]Brewer, G.J., Yuzbasiyan-Gurkan, V., and Young, A.B. Treatment of Wilsons disease. Semin Neurol. 1987; 7: 209220
CrossRef | PubMed

[121]Brewer, G.J., Hill, G.M., Prasad, A.S., Cossack, Z.T., and Rabbani, P. Oral zinc therapy for Wilsons disease. Ann Intern Med. 1983; 99: 314319
CrossRef | PubMed

[122]Hoogenraad, T.U. Zinc treatment of Wilsons disease. J Lab Clin Med. 1998; 132: 240241
PubMed

[123]Cousins, R.J. Absorption, transport and hepatic metabolism of copper and zinc: special reference to metallothionein and ceruloplasmin. Physiol Rev. 1985; 65: 238309
PubMed

[124]Schilsky, M., Blank, R.R., Czaja, M.J., Scheinberg, I.H., Stockert, R.J., and Sternlieb, I. Hepatocellular copper toxicity and its attenuation by zinc. J Clin Invest. 1989; 84: 15621568
CrossRef | PubMed

[125]Pecoud, A., Dozel, F., and Schelling, J.L. The effect of foodstuffs on the absorption of zinc sulfate. Clin Pharmacol Ther. 1975; 17: 469474
PubMed

[126]Ferenci P. Zinc treatment of Wilsons disease. In: Kruse-Jarres JD, Schlmerich J, editors. Zinc and diseases of the digestive tract. Lancaster: Kluwer Academic Publishers;1997. p. 117124.

[127]Walshe, J.M. and Munro, N.A. Zinc-induced deterioration in Wilsons disease aborted by treatment with penicillamine, dimercaprol, and a novel zero copper diet. Arch Neurol. 1995; 52: 1011
CrossRef | PubMed

[128]Linn, F.H., Houwen, R.H., van Hattum, J., van der Kleij, S., and van Erpecum, K.J. Long-term exclusive zinc monotherapy in symptomatic Wilson disease: experience in 17 patients. Hepatology. 2009; 50: 14421452
CrossRef | PubMed | Scopus (25)

[129]Weiss, K.H., Gotthardt, D., Klemm, D., Merle, U., Ferenci-Foerster, D., Schaefer, M. et al. Zinc monotherapy is not as effective as chelating agents in treatment of Wilson disease. Gastroenterology. 2011; 140: 11891198
Abstract | Full Text | Full Text PDF | PubMed | Scopus (18)

[130]Roberts, E.A. and Schilsky, M.L. AASLD practice guidelines: a practice guideline on Wilson disease. Hepatology. 2008; 47: 20942108
CrossRef | Scopus (193)

[131]Walshe, J.M. and Yealland, M. Chelation treatment of neurological Wilsons disease. Q J Med. 1993; 86: 197204
PubMed

[132]Fryer, M.J. Potential of vitamin E as an antioxidant adjunct in Wilsons disease. Med Hypotheses. 2009; 73: 10291030
PubMed | Scopus (4)

[133]Shen, L. and Ji, H.F. Adjunctive vitamin E treatment in Wilson disease, suggestions for future trials. Hepatology. 2010; 51: 1864
CrossRef | PubMed | Scopus (1)

[134]von Herbay, A., de Groot, H., Hegi, U., Stremmel, W., Strohmeyer, G., and Sies, H. Low vitamin E content in plasma of patients with alcoholic liver disease, hemochromatosis and Wilsons disease. J Hepatol. 1994; 20: 4146
PubMed

[135]Sinha, S., Christopher, R., Arunodaya, G.R., Prashanth, L.K., Gopinath, G., Swamy, H.S. et al. Is low serum tocopherol in Wilsons disease a significant symptom?. J Neurol Sci. 2005; 228: 121123
PubMed | Scopus (11)

[136]Sokol, R.J., Twedt, D., McKim, J.M. Jr, Devereaux, M.W., Karrer, F.M., Kam, I. et al. Oxidant injury to hepatic mitochondria in patients with Wilsons disease and Bedlington terriers with copper toxicosis. Gastroenterology. 1994; 107: 17881798
PubMed

[137]Lang, P.A., Schenck, M., Nicolay, J.P., Becker, J.U., Kempe, D.S., Lupescu, A. et al. Liver cell death and anemia in Wilson disease involve acid sphingomyelinase and ceramide. Nature Med. 2007; 13: 164170
CrossRef | PubMed | Scopus (165)

[138]van den Berghe, P.V., Stapelbroek, J.M., Krieger, E., de Bie, P., van de Graaf, S.F., de Groot, R.E. et al. Reduced expression of ATP7B affected by Wilson disease-causing mutations is rescued by pharmacological folding chaperones 4-phenylbutyrate and curcumin. Hepatology. 2009; 50: 17831795
CrossRef | PubMed | Scopus (26)

[139]Sreejayan and Rao, M.N. Nitric oxide scavenging by curcuminoids. J Pharm Pharmacol. 1997; 49: 105107
CrossRef | PubMed

[140]Barik, A., Mishra, B., Shen, L., Mohan, H., Kadam, R.M., Dutta, S. et al. Evaluation of a new copper(II)-curcumin complex as superoxide dismutase mimic and its free radical reactions. Free Radic Biol Med. 2005; 39: 811822
CrossRef | PubMed | Scopus (82)

[141]Khanna, A., Jain, A., Eghtesad, B., and Rakela, J. Liver transplantation for metabolic liver diseases. Surg Clin North Am. 1999; 79: 153162
PubMed | Scopus (15)

[142]Schilsky, M.L., Scheinberg, I.H., and Sternlieb, I. Liver transplantation for Wilsons disease: indications and outcome. Hepatology. 1994; 19: 583587
CrossRef | PubMed

[143]Bellary, S., Hassanein, T., and Van Thiel, D.H. Liver transplantation for Wilsons disease. J Hepatol. 1995; 23: 373381
PubMed | Scopus (62)

[144]Yoshitoshi, E.Y., Takada, Y., Oike, F., Sakamoto, S., Ogawa, K., Kanazawa, H. et al. Long-term outcomes for 32 cases of Wilsons disease after living-donor liver transplantation. Transplantation. 2009; 87: 261267
CrossRef | PubMed | Scopus (10)

[145]Schumacher, G., Platz, K.P., Mueller, A.R., Neuhaus, R., Luck, W., Langrehr, J.M. et al. Liver transplantation in neurologic Wilsons disease. Transplant Proc. 2001; 33: 15181519
PubMed | Scopus (15)

[146]Cheng, F., Li, G.Q., Zhang, F., Li, X.C., Sun, B.C., Kong, L.B. et al. Outcomes of living-related liver transplantation for Wilsons disease: a single-center experience in China. Transplantation. 2009; 87: 751757
CrossRef | PubMed | Scopus (10)

[147]Litwin, T., Gromadzka, G., and Czlonkowska, A. Neurological presentation of Wilsons disease in a patient after liver transplantation. Mov Disord. 2008; 23: 743746
CrossRef | PubMed | Scopus (6)

[148]Scheinberg, I.H. and Sternlieb, I. Pregnancy in penicillamine-treated patients with Wilsons disease. N Engl J Med. 1975; 293: 13001302
CrossRef | PubMed

[149]Brewer, G.J., Johnson, V.D., Dick, R.D., Hedera, P., Fink, J.K., and Kluin, K.J. Treatment of Wilsons disease with zinc XVII: treatment during pregnancy. Hepatology. 2000; 31: 364370
CrossRef | PubMed

[150]Ferenci P. Wilsons Disease. In: Bacon B, OGrady JG, DiBisceglie A, Lake JR, editors. Comprehensive clinical hepatology. [Chapter 24]. Maryland Heights, Miss. USA: Elsevier Mosby; 2005. p. 351367.

[151]Sinha, S., Taly, A.B., Prashanth, L.K., Arunodaya, G.R., and Swamy, H.S. Successful pregnancies and abortions in symptomatic and asymptomatic Wilsons disease. J Neurol Sci. 2004; 217: 3740
PubMed | Scopus (14)

[152]Walshe, J.M. The management of pregnancy in Wilsons disease treated with trientine. Q J Med. 1986; 58: 8187
PubMed

[153]Messner, U., Gnter, H.H., and Niesert, S. Wilson disease and pregnancy. Review of the literature and case report. Z Geburtshilfe Neonatol. 1998; 202: 7779
PubMed

[154]Rubinfeld, Y., Maor, Y., Simon, D., and Modai, D. A progressive rise in serum copper levels in women taking oral contraceptives: a potential hazard?. Fertil Steril. 1979; 32: 599601
PubMed

[155]Garmizo, G. and Frauens, B.J. Corneal copper deposition secondary to oral contraceptives. Optom Vis Sci. 2008; 85: E802E807
CrossRef | PubMed | Scopus (5)

[156]Haimov-Kochman R, Ackerman Z, Anteby EY. The contraceptive choice for a Wilsons disease patient with chronic liver disease. Contraception 1997;56:241244.

[157]Walshe, J.M. Wilsons disease presenting with features of hepatic dysfunction: a clinical analysis of eightyseven patients. Q J Med. 1989; 70: 253263
PubMed

[158]Scott, J., Gollan, J.L., Samourian, S., and Sherlock, S. Wilsons disease, presenting as chronic active hepatitis. Gastroenterology. 1978; 74: 645651
PubMed

[159]Guyatt, G.H., Oxman, A.D., Vist, G.E., Kunz, R., Falck-Ytter, Y., Alono-Coello, P. et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008; 336: 924926
CrossRef | PubMed